이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Olfactory Communication in the First Days of Life: From Chemical Mechanisms to Improved Breastfeeding (OD-ALL)

2026년 5월 26일 업데이트: Centre Hospitalier Universitaire Dijon

For a newborn, locating and latching onto the mother's breast is the foundational social interaction. This pivotal moment not only influences the newborn's survival but also determines the mother's physiological (lactation) and psychological (attachment) engagement, as well as the long-term health of both the child and the mother. However, according to the WHO, three out of five newborns are not exclusively breastfed for the recommended 6 months, and several recent studies point to suboptimal rates of breastfeeding initiation in the maternity ward, partly due to difficulties with oral latching, insufficient sucking, or refusal of the breast. This situation compromises the initial intake of colostrum/milk, as well as the establishment of early emotional bonds. A wealth of research data from biology, psychology, and pediatrics shows that neonatal and maternal sensory experiences play a central role in the initiation of breastfeeding. However, our understanding of the sensory and behavioral mechanisms at play remains unclear. While visual and auditory interactions have been extensively documented, other sensory modalities-touch, chemoreception, and kinesthesia-remain largely overlooked, even though their critical role has been documented in other mammals. The inves will focus on the role of olfaction in organizing the adaptive responses of the newborn to the mother's breast and of the mother to her baby.

A wealth of research data from biology, psychology, and pediatrics shows that neonatal and maternal sensory experiences play a central role in the initiation of breastfeeding. However, our understanding of the sensory and behavioral mechanisms involved remains unclear. While visual and auditory interactions have been extensively documented, other sensory modalities-touch, chemoreception, and kinesthesia-have received little attention, even though their critical role has been documented in other mammals. Here, the investigators will focus on the role of olfaction in organizing the adaptive responses of the newborn to the mother's breast and of the mother to her baby.

Research data in humans show that: 1) several mammary secretions (colostrum/milk, areolar secretions) emit odorous compounds, and 2) newborns respond to them in a stereotypical and repeatable manner. These odors, which are specific to the mammary gland, serve to facilitate the very first mother-infant interactions. However, the source of these odorous compounds remains unclear, and their chemical nature is unknown. Without precise chemical identification, it is difficult to fully understand the mechanisms by which odors influence the newborn's behavior toward the mother's breast at the start of breastfeeding. Conversely, the newborn's body odors could also convey information about its emotional or metabolic state and influence maternal motivation and behavior.

Based on research conducted on other mammals, as well as studies focused on our own species, the investigators know that: 1) postpartum mothers are highly receptive to the body odor of their newborns, and 2) newborns emit odor compounds that are appreciated by mothers (even if the infants are not their own) . It cannot therefore be ruled out that human mothers react, even unconsciously, to these infant odors and that these odors could help regulate maternal psychophysiology (particularly that underlying lactation and the related chemocommunication mechanisms).

The OD-ALL project aims to unravel the chemical basis of the olfactory interactions that lead to the establishment of the breastfeeding relationship between each member of the mother-newborn dyad. To this end, the investigators will apply an innovative technology, proton transfer reaction time-of-flight mass spectrometry (PTR-ToF-MS), which has previously been used to monitor volatile organic compounds (VOCs) in the environment. Unlike conventional techniques (such as gas chromatography coupled with mass spectrometry; GC-MS), which allow only sporadic and somewhat disruptive measurements, PTR-ToF-MS records odor emissions in real time, without any disruption to the natural interactions taking place. It is capable of providing a true "chemical video" of the dynamic variations in VOCs of mammary or infant origin (whereas conventional GC-MS provides only a "chemical snapshot"). These fluctuations can thus be correlated with the behaviors and physiological responses of mothers and newborns, which will be recorded concurrently. This approach opens up entirely new avenues for understanding the chemosensory foundations of early human interactions, particularly those that occur during the initiation of breastfeeding. Alongside this fundamental approach, the OD-ALL project aims to raise awareness among healthcare professionals, the general public and health policy makers regarding the role of smell in early interactions between mother and newborn.

연구 개요

연구 유형

관찰

등록 (추정된)

364

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 어린이
  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

샘플링 방법

비확률 샘플

연구 인구

Breastfeeding women who have given birth to a single newborn / who may be accompanied by their newborn

설명

Inclusion Criteria:

  • Regarding mothers:

    • Individuals who have provided their consent (studies 1, 2, and 3) as well as that of their child (studies 1 and 3).
    • Adults.
    • Birth of a singleton newborn.
    • Breastfeeding woman (studies 1 and 2).
    • Absence of any infectious risk and any prior morbidity during pregnancy, childbirth, and breastfeeding (determined by medical staff).
  • Regarding newborns:

    • Absence of medical problems during pregnancy, at delivery (full-term birth: 37-42 weeks of amenorrhea, Apgar score > 7 at 1 and 10 minutes; birth weight > 2500 g), or during the neonatal period.

Exclusion Criteria:

  • Regarding mothers:

    • Any mother with an infectious disease (HIV, hepatitis A or B) or under special medical supervision.
    • Mothers taking medication that may alter body odor (e.g., corticosteroids, progestins, antidepressants).
    • Mothers who smoke.
    • Mothers suffering from chronic (confirmed congenital anosmia) or acute impairments of the sense of smell (nasal congestion due to infection or allergy).
    • Mothers subject to legal protective measures (guardianship, conservatorship).
    • Mothers subject to judicial protective measures.
  • Regarding newborns:

    • Any child who experienced medical problems during pregnancy, childbirth, or the neonatal period (Apgar score < 7 at 1, 5, and 10 minutes).
    • Congenital anosmia (if this information is noted in the medical record; for example, in cases of Du Morsier-Kallman syndrome).

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

코호트 및 개입

그룹/코호트
개입 / 치료
44 mother-newborn pairs
44 mother-newborn pairs (i.e., n = 44 mothers et n = 44 newborn)
VOC measurement during a breastfeeding session + video and thermographic recording
42 mothers
42 mothers (collection of areolar secretions)
Breast secretion samples
164 mothers
Measurement of VOCs during a film screening featuring various sensory characteristics of children + video and thermographic recording
57 awake newborns
Measurement of psychophysiological responses in sleeping newborns during exposure to maternal odors + video and thermographic recording
Measurement of sucking responses in awake newborns during exposure to maternal odors + video and thermographic recording
57 sleeping newborns
Measurement of psychophysiological responses in sleeping newborns during exposure to maternal odors + video and thermographic recording
Measurement of sucking responses in awake newborns during exposure to maternal odors + video and thermographic recording

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
기간
Temporal variations in the occurrence of VOCs emitted in the odor of the lactating breast, measured in real time using proton transfer mass spectrometry
기간: Before, during, and after feeding, at day 0 during 3 hours
Before, during, and after feeding, at day 0 during 3 hours
Temporal variations in the relative concentration of VOCs emitted in the breath of nursing mothers, measured in real time using proton transfer mass spectrometry
기간: Before, during, and after feeding, at day 0 during few minutes
Before, during, and after feeding, at day 0 during few minutes
Maternal responsiveness (breast interoception, breast thermography measured by concurrent chemical analysis (PTR-ToF-MS) to identify systematic variations in the VOCs of breast odor) during visual, auditory, and olfactory presentation to the child video
기간: While breastfeeding at day 0 during 1 hour
While breastfeeding at day 0 during 1 hour
Behavioral responses in newborns exposed to samples of breast milk or to VOCs present in breast milk vapors, as measured by orofacial motor activity in sleeping newborns during active sleep phases
기간: While breastfeeding at day O during 30 to 45 minutes
While breastfeeding at day O during 30 to 45 minutes
Psychophysiological responses in newborns exposed to samples of breast milk or to VOCs present in breast milk vapors, as measured by heart and respiratory rates in sleeping newborns during active sleep phases
기간: While breastfeeding at day O during 30 to 45 minutes
While breastfeeding at day O during 30 to 45 minutes

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 5월 1일

기본 완료 (추정된)

2032년 5월 1일

연구 완료 (추정된)

2032년 5월 1일

연구 등록 날짜

최초 제출

2026년 5월 11일

QC 기준을 충족하는 최초 제출

2026년 5월 26일

처음 게시됨 (실제)

2026년 5월 29일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 5월 29일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 5월 26일

마지막으로 확인됨

2026년 5월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • SIMON Stirling 2025

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다